Testing effectiveness (Phase 2)UnknownNCT04952493What this trial is testingAnlotinib or Penpulimab in Combination With RAI for DTCWho this might be right forThyroid Cancer Peking Union Medical College Hospital 42
Testing effectiveness (Phase 2)Looking for participantsNCT06970353What this trial is testingPhase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid CancerWho this might be right forRadioactive Iodine-refractory, Differentiated Thyroid Cancer With NRAS MutationAdvanced PDTC or ATC With NRAS Mutation Fudan University 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05007093What this trial is testingStudy on the Treatment of Differentiated Thyroid Carcinoma with AnlotinibWho this might be right forDTC - Differentiated Thyroid Cancer Yansong Lin 20
Testing effectiveness (Phase 2)UnknownNCT01830504What this trial is testingPhase II Pilot Open LabelWho this might be right forThyroid Cancers Hospices Civils de Lyon 47
Testing effectiveness (Phase 2)Study completedNCT02614495What this trial is testingStudy of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid CarcinomaWho this might be right forThyroid Carcinoma Hutchison Medipharma Limited 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT04171622What this trial is testingLenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid CancerWho this might be right forMetastatic Thyroid Gland CarcinomaPoorly Differentiated Thyroid Gland CarcinomaStage IVB Thyroid Gland Anaplastic Carcinoma AJCC v8+3 more M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT01182285What this trial is testingA Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell OriginWho this might be right forThyroid Neoplasm National Cancer Institute (NCI) 13
Testing effectiveness (Phase 2)WithdrawnNCT04731740What this trial is testingPembrolizumab and Lenvatinib/Chemotherapy for Poorly Differentiated/Anaplastic Thyroid CancerWho this might be right forMetastatic Thyroid Gland CarcinomaPoorly Differentiated Thyroid Gland CarcinomaThyroid Gland Anaplastic Carcinoma by AJCC V8 Stage Saint Petersburg State University, Russia
Not applicableLooking for participantsNCT07068542What this trial is testingSacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid CancerWho this might be right forAdvanced Thyroid CarcinomaRadioiodine-refractory Differentiated Thyroid CancerPoorly Differentiated Thyroid Carcinoma Zhejiang Provincial People's Hospital 94
Large-scale testing (Phase 3)UnknownNCT03048877What this trial is testingEfficacy of Apatinib in Radioactive Iodine-refractory Differentiated Thyroid CancerWho this might be right forDifferentiated Thyroid Cancer Peking Union Medical College Hospital 118
Large-scale testing (Phase 3)Study completedNCT00984282What this trial is testingNexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid CancerWho this might be right forThyroid Neoplasms Bayer 417
Not applicableActive Not RecruitingNCT04970134What this trial is testingSpanish Study for Molecular Characterization of Thyroid CarcinomaWho this might be right forDifferentiated Thyroid CarcinomaMedullary Thyroid Carcinoma Grupo Español de Tratamiento de Tumores de Cabeza y Cuello 150
Testing effectiveness (Phase 2)UnknownNCT03387943What this trial is testingPLD Combined With Cisplatin in the Treatment of Advanced Poorly Differentiated Thyroid CarcinomaWho this might be right forPoorly Differentiated Thyroid Carcinoma CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 30
Not applicableLooking for participantsNCT06431620What this trial is testingSafety and Efficacy of Recombinant Human Thyroid Stimulating Hormone for Adjuvant Diagnosis in Patients With Locally Advanced/Metastatic Differentiated Thyroid CancerWho this might be right forRecombinant Human Thyroid Stimulating Hormone Nanjing First Hospital, Nanjing Medical University 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07193186What this trial is testingAnlotinib and Benmelstobart in DTCWho this might be right forThyroid Cancer Fudan University 23
Early research (Phase 1)Not Yet RecruitingNCT07252661What this trial is testingStudy of ACC-1898 in Adult Participants With Advanced Solid TumorsWho this might be right forHepatocellular CarcinomaRenal Cell CarcinomaThyroid Carcinoma, Medullary+6 more AccSalus Biosciences, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT05660954What this trial is testingCabozantinib In Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer.Who this might be right forDifferentiated Thyroid Cancer Grupo Espanol de Tumores Neuroendocrinos 41
Not applicableUnknownNCT02156362What this trial is testingDetermination of Pronostics Factors for Advanced Thyroid Carcinoma (pT3 pT4 or M1 at Diagnosis)Who this might be right forThyroid Cancer Hospices Civils de Lyon 643
Testing effectiveness (Phase 2)Active Not RecruitingNCT03914300What this trial is testingTesting the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid CancerWho this might be right forDifferentiated Thyroid Gland CarcinomaFollicular Variant Thyroid Gland Papillary CarcinomaPoorly Differentiated Thyroid Gland Carcinoma+6 more National Cancer Institute (NCI) 11
Large-scale testing (Phase 3)Looking for participantsNCT06860971What this trial is testingAL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid CarcinomaWho this might be right forThyroid Cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 144